Freenome (FRNM)
Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detectio...
- Open
- 15.950
- High
- 16.225
- Low
- 15.370
- Prev. Close
- 16.010
- Volume
- 418.85K
- Turnover
- 6.61M
- Avg Price
- 15.793
- Bid/Ask Ratio
- --
- Amplitude
- 5.34%
- 52wk High
- 17.500
- Volume Ratio
- 0.51
- Turnover Ratio
- 0.61%
Freenome Analyst Rating
View moreForecast & Rating
Aug 20, 2026Price forecast
$18.0012.57%
Forecast & RatingStrong buy
5analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- rttnews · Sep 21 at 01:38 PM
Biotech Stocks At 52-Week Highs - HSCS +7%, FRNM +5%, VOGX, HTFL, HALO
- Market Beat · Aug 27 at 08:00 PM
Freenome (NASDAQ:FRNM) Sees Large Growth in Short Interest
- PUBT · Aug 12 at 03:15 PM
FDA grants Breakthrough Device designation to Freenome SimpleScreen Lung test
- TradingView · Jul 27 at 12:13 PM
Freenome's SimpleScreen CRC gains FDA approval; $100M Abbott milestone, Medicare coverage expected
